Financial reports
10-K
2023 FY
Annual report
21 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
3 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
17 Mar 22
Current reports
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
22 Mar 24
8-K
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update
21 Mar 24
8-K
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva
4 Mar 24
8-K
Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update
14 Nov 23
8-K
Departure of Directors or Certain Officers
20 Sep 23
8-K
Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update
14 Aug 23
8-K
Departure of Directors or Certain Officers
19 Jul 23
8-K
Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics
11 Jul 23
8-K
Results of Operations and Financial Condition
27 Jun 23
8-K
Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update
11 May 23
Registration and prospectus
S-8
Registration of securities for employees
23 Jan 24
S-8
Registration of securities for employees
15 Nov 23
424B3
Prospectus supplement
6 Apr 23
S-3/A
Shelf registration (amended)
28 Mar 23
S-3
Shelf registration
13 Feb 23
424B3
Prospectus supplement
31 May 22
S-3/A
Shelf registration (amended)
23 May 22
S-3
Shelf registration
13 May 22
424B3
Prospectus supplement
6 Apr 22
S-3
Shelf registration
29 Mar 22
Proxies
DEFA14A
Additional proxy soliciting materials
3 Aug 23
DEF 14A
Definitive proxy
3 Aug 23
PRE 14A
Preliminary proxy
24 Jul 23
DEF 14A
Definitive proxy
17 Oct 22
DEF 14A
Definitive proxy
9 Mar 22
PRE 14A
Preliminary proxy
24 Feb 22
DEFA14A
Additional proxy soliciting materials
22 Apr 21
DEF 14A
Definitive proxy
21 Apr 21
DEF 14A
Definitive proxy
26 Feb 21
PRE 14A
Preliminary proxy
9 Feb 21
Other
UPLOAD
Letter from SEC
13 Nov 23
CORRESP
Correspondence with SEC
7 Nov 23
UPLOAD
Letter from SEC
26 Oct 23
EFFECT
Notice of effectiveness
7 Apr 23
CORRESP
Correspondence with SEC
5 Apr 23
UPLOAD
Letter from SEC
17 Feb 23
EFFECT
Notice of effectiveness
1 Jun 22
CORRESP
Correspondence with SEC
26 May 22
UPLOAD
Letter from SEC
19 May 22
EFFECT
Notice of effectiveness
7 Apr 22
Ownership